Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Four things you should know to be #HepAware.
It’s Hepatitis Awareness Month. Find out if money poses a risk for transmitting viral hepatitis.
Just over half of people who use drugs in eight cities are hepatitis C virus antibody positive.
The state’s health department is providing free testing to clients.
But experts advise caution, as the drug may worsen other liver diseases, including viral hepatitis.
In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.
But the health secretary does not support safe injection sites.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
Interestingly, the drugs themselves, not just the act of curing the virus, were tied to a lower diabetes risk in a recent large study.
All women who completed follow-up in a small trial were cured, and none of their infants contracted the virus.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
Nearly 3,800 patients at the New Jersey surgery center may have been exposed, though the risk of infection is low.
This is according to the largest-ever analysis of the treatment cascade among people tested for hepatitis C.
Preliminary results from an ongoing trial found that half of the participants could take less than 12 weeks of a cure regimen.
Thus far, no state prison systems have adopted the protocols that advocates are demanding.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.